Search

everythinglearnresearchcommunity

for

Search:↓

The link between pemphigus and the patient's scarring hair loss is still unclear.

Adding platelet rich plasma to follicular unit extraction doesn't significantly improve hair graft survival in cicatricial alopecia treatment.

Adding platelet rich plasma to hair transplant surgery leads to better results and more patient satisfaction.

Certain genes and proteins may help diagnose and treat primary cicatricial alopecia.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

The "spade sign" is a highly specific indicator for diagnosing acne keloidalis.

Hair shaft malformation contributes to Central Centrifugal Cicatricial Alopecia.

Mutations in the PADI3 gene may cause central centrifugal cicatricial alopecia in women of African ancestry.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

The document concludes that a woman has both Frontal Fibrosing Alopecia and Lichen Simplex Chronicus, a previously unreported combination of conditions.

Surgical methods for hair loss due to scarring should be chosen based on the size, location, and shape of the area, with most patients seeing good results.

Dense-packing hair grafting is a simple, safe, and effective way to restore hair in people with cicatricial alopecia.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

There is no standard treatment for CCCA, and practices vary widely.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Low-dose metformin may help hair regrowth and reduce inflammation in CCCA.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Accurate diagnosis is crucial for effective treatment of hair loss.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.